Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q44462005

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Gemtuzumab ozogamicin in combi ...... actory acute myeloid leukemia.

@en

Gemtuzumab ozogamicin in combi ...... actory acute myeloid leukemia.

@nl

type

Item

label

Gemtuzumab ozogamicin in combi ...... actory acute myeloid leukemia.

@en

Gemtuzumab ozogamicin in combi ...... actory acute myeloid leukemia.

@nl

prefLabel

Gemtuzumab ozogamicin in combi ...... actory acute myeloid leukemia.

@en

Gemtuzumab ozogamicin in combi ...... actory acute myeloid leukemia.

@nl

P1476

Gemtuzumab ozogamicin in combi ...... actory acute myeloid leukemia.

@en

P2093

Anne-Claire Gac

http://www.w3.org/2001/XMLSchema#string

Emilie Reboursiere

http://www.w3.org/2001/XMLSchema#string

Hyacinthe Johnsonansah

http://www.w3.org/2001/XMLSchema#string

Jean-Baptiste Mear

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Vilque

http://www.w3.org/2001/XMLSchema#string

Khaled Benabed

http://www.w3.org/2001/XMLSchema#string

Margaret Macro

http://www.w3.org/2001/XMLSchema#string

Oumedaly Reman

http://www.w3.org/2001/XMLSchema#string

Stéphane Cheze

http://www.w3.org/2001/XMLSchema#string

Veronique Salaun

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.

High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse.

High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.

Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells.

Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.

Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience.

Outcome of older patients with acute myeloid leukemia in first relapse.

P304

2326-2330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2014.986478

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sylvain Chantepie

P577

2014-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25393676

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy